Mortality as an endpoint in atrial fibrillation

Heart Rhythm

Volumn 1, Issue 2 SUPPL., 2004, Pages 8-19

  Beyerbach, Daniel M ^a   Zipes, Douglas P ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anticoagulation; Epidemiology; Stroke; Sudden death; Ventricular arrhythmia

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; AZIMILIDE; COUMARIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOFETILIDE; METOPROLOL; PLACEBO; PROPAFENONE; SOTALOL; WARFARIN;

ANTICOAGULANT THERAPY; CATHETER ABLATION; CLINICAL STUDY; CLINICAL TRIAL; DEFIBRILLATOR; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART FAILURE; HEART INFARCTION; HEART RATE; HEART RHYTHM; HEART SURGERY; HUMAN; MORTALITY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SINUS RHYTHM; STROKE; SURGICAL TECHNIQUE; THROMBOEMBOLISM; VALIDATION PROCESS;

EID: 3042733004     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2004.04.018     Document Type: Article

References (99)

1. Wyse D.G. Selection of endpoints in atrial fibrillation studies J Cardiovasc Electrophysiol 131 Suppl 2002 S47-S52
2. Kannel W.B. Abbott R.D. Savage D.D. McNamara P.M. Epidemiologic features of chronic atrial fibrillation: the Framingham study N Engl J Med 306 1982 1018-1022
3. Krahn A.D. Manfreda J. Tate R.B. Mathewson F.A. Cuddy T.E. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study Am J Med 98 1995 476-484
4. Wolf P.A. Mitchell J.B. Baker C.S. Kannel W.B. D'Agostino R.B. Impact of atrial fibrillation on mortality, stroke, and medical costs Arch Intern Med 158 1998 229-234
5. Stewart S. Hart C.L. Hole D.J. McMurray J.J. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study Am J Med 113 2002 359-364
6. Vidaillet H. Granada J.F. Chyou P.H. Maassen K. Ortiz M. Pulido J.N. Sharma P. Smith P.N. Hayes J. A population-based study of mortality among patients with atrial fibrillation or flutter Am J Med 113 2002 365-370
7. Benjamin E.J. Wolf P.A. D'Agostino R.B. Silbershatz H. Kannel W.B. Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946-952
8. Hellemons B.S. Langenberg M. Lodder J. Vermeer F. Schouten H.J. Lemmens T. van Ree J.W. Knottnerus J.A. Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin. The PATAF trial BMJ 319 1999 958-964
9. Gullov A.L. Koefoed B.G. Petersen P. Pedersen T.S. Andersen E.D. Godtfredsen J. Boysen G. Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study (AFASAK-2) Arch Intern Med 158 1998 1513-1521
10. Stroke Prevention in Atrial Fibrillation Study Group Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial (SPAF-III) Lancet 348 1996 633-638
11. Stroke Prevention in Atrial Fibrillation Investigators Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study (SPAF-II) Lancet 343 1994 687-691
12. Atrial Fibrillation Investigators Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials Arch Intern Med 154 1994 1449-1457
13. European Atrial Fibrillation Trial (EAFT) Study Group Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke Lancet 342 1993 1255-1262
14. Ezekowitz M.D. Bridgers S.L. James K.E. Carliner N.H. Colling C.L. Gornick C.C. Krause-Steinrauf H. Kurtzke J.F. Nazarian S.M. Radford M.J. et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation (SPINAF) Investigators N Engl J Med 327 1993 1406-1412
15. Stroke Prevention in Atrial Fibrillation Investigators Stroke Prevention in Atrial Fibrillation (SPAF) study. Final results Circulation 84 1991 527-539
16. Connolly S.J. Laupacis A. Gent M. Roberts R.S. Cairns J.A. Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) study J Am Coll Cardiol 18 1991 349-355
17. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The BAATAF trial N Engl J Med 323 1990 1505-1511
18. Petersen P. Boysen G. Godtfredsen J. Andersen E.D. Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study Lancet 1 1989 175-179
19. Wyse D.G. Rhythm versus rate control trials in atrial fibrillation J Cardiovasc Electrophysiol 14 9 Suppl 2003 S35-S39
20. Wyse D.G. Rhythm management in atrial fibrillation: less is more J Am Coll Cardiol 41 2003 1703-1706
21. STAF Investigators Carlsson J. Miketic S. Windeler J. Cuneo A. Haun S. Micus S. Walter S. Tebbe U. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study J Am Coll Cardiol 41 2003 1690-1696
22. Van Gelder I.C. Hagens V.E. Bosker H.A. Kingma J.H. Kamp O. Kingma T. Said S.A. Darmanata J.I. Timmermans A.J. Tijssen J.G. Crijns H.J. Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) Study Group A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834-1840
23. Wyse D.G. Waldo A.L. DiMarco J.P. Domanski M.J. Rosenberg Y. Schron E.B. Kellen J.C. Greene H.L. Mickel M.C. Dalquist J.E. Corley S.D. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825-1833
24. Brignole M. Menozzi C. Gasparini M. Bongiorni M.G. Botto G.L. Ometto R. Alboni P. Bruna C. Vincenti A. Verlato R. on behalf of the PAF 2 Study Investigators An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation. The Paroxysmal Atrial Fibrillation 2 (PAF 2) Trial Eur Heart J 23 2002 892-900
25. Hohnloser S.H. Kuck K.H. Lilienthal J. Rhythm or rate control in atrial fibrillation-pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial Lancet 356 2000 1789-1794
26. AF-CHF Trial Investigators Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial Am Heart J 144 2002 597-607
27. Brendorp B. Pedersen O. Torp-Pedersen C. Sahebzadah N. Kober L. A benefit-risk assessment of class III antiarrhythmic agents Drug Saf 25 2002 847-865
28. Echt D.S. Liebson P.R. Mitchell L.B. Peters R.W. Obias-Manno D. Barker A.H. Arensberg D. Baker A. Friedman L. Greene H.L. et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial (CAST) N Engl J Med 324 1991 781-788
29. Cardiac Arrhythmia Suppression Trial II (CAST II) Investigators Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction N Engl J Med 327 1992 227-233
30. Waldo A.L. Camm A.J. deRuyter H. Friedman P.L. MacNeil D.J. Pauls J.F. Pitt B. Pratt C.M. Schwartz P.J. Veltri E.P. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol Lancet 348 1996 7-12
31. Siebels J. Kuck K.H. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg) Am Heart J 127 4 Pt 2 1994 1139-1144
32. Brendorp B. Elming H. Jun L. Kober L. Malik M. Jensen G.B. Torp-Pedersen C. DIAMOND Study Group QTc interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with dofetilide Circulation 103 2001 1422-1427
33. Wyse D.G. Love J.C. Yao Q. Carlson M.D. Cassidy P. Greene L.H. Martins J.B. Ocampo C. Raitt M.H. Schron E. Stamato N.J. Olarte A. Atrial fibrillation: a risk factor for increased mortality: an AVID registry analysis J Interv Card Electrophysiol 5 2001 267-273
34. Coplen S.E. Antman E.M. Berlin J.A. Hewitt P. Chalmers T.C. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials Circulation 82 1990 1106-1116
35. Reimold S.C. Chalmers T.C. Berlin J.A. Antman E.M. Assessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation: observations on the role of trial design and implications of drug-related mortality Am Heart J 124 1992 924-932
36. Flaker G.C. Blackshear J.L. McBride R. Kronmal R.A. Halperin J.L. Hart R.G. The Stroke Prevention in Atrial Fibrillation Investigators Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation J Am Coll Cardiol 20 1992 527-532
37. Naccarelli G.V. Wolbrette D.L. Khan M. Bhatta L. Hynes J. Samii S. Luck J. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials Am J Cardiol 91 6A 2003 15D-26D
38. Giri S. White C.M. Dunn A.B. Felton K. Freeman-Bosco L. Reddy P. Tsikouris J.P. Wilcox H.A. Kluger J. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial Lancet 357 2001 830-836
39. Roy D. Talajic M. Dorian P. Connolly S. Eisenberg M.J. Green M. Kus T. Lambert J. Dubuc M. Gagne P. Nattel S. Thibault B. Canadian Trial of Atrial Fibrillation (CTAF) Investigators Amiodarone to prevent recurrence of atrial fibrillation N Engl J Med 342 2000 913-920
40. Pritchett E.L. Page R.L. Connolly S.J. Marcello S.R. Schnell D.J. Wilkinson W.E. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response J Am Coll Cardiol 36 2000 794-802
41. Kuhlkamp V. Schirdewan A. Stangl K. Homberg M. Ploch M. Beck O.A. Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study J Am Coll Cardiol 36 2000 139-146
42. Singh S. Zoble R.G. Yellen L. Brodsky M.A. Feld G.K. Berk M. Billing C.B. Jr Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study Circulation 102 2000 2385-2390
43. Torp-Pedersen C. Moller M. Bloch-Thomsen P.E. Kober L. Sandoe E. Egstrup K. Agner E. Carlsen J. Videbaek J. Marchant B. Camm A.J. Danish Investigations of Arrhythmia and Mortality on Dofetilide (DIAMOND-HF) Study Group Dofetilide in patients with congestive heart failure and left ventricular dysfunction N Engl J Med 341 1999 857-865
44. Kober L. Bloch-Thomsen P.E. Moller M. Torp-Pedersen C. Carlsen J. Sandoe E. Egstrup K. Agner E. Videbaek J. Marchant B. Camm A.J. Danish Investigations of Arrhythmia and Mortality on Dofetilide (DIAMOND-MI) Study Group Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial Lancet 356 2000 2052-2058
45. Oral H. Souza J.J. Michaud G.F. Knight B.P. Goyal R. Strickberger S.A. Morady F. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment N Engl J Med 340 1999 1849-1854
46. Guarnieri T. Nolan S. Gottlieb S.O. Dudek A. Lowry D.R. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial J Am Coll Cardiol 34 1999 343-347
47. Gomes J.A. Ip J. Santoni-Rugiu F. Mehta D. Ergin A. Lansman S. Pe E. Newhouse T.T. Chao S. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study J Am Coll Cardiol 34 1999 334-339
48. Greenbaum R.A. Campbell T.J. Channer K.S. Dalrymple H.W. Kingma J.H. Santini M. Theisen K. Toivonnen L.K. Conversion of atrial fibrillation and maintenance of sinus rhythm by dofetilide. The European and Australian Multicenter Evaluative Research on Atrial Fibrillation Dofetilide (EMERALD) Study Circulation 98 1998 I-633 (abstr)
49. Lee J. Atrial fibrillation: the nonpharmacologic strategy Mt Sinai J Med 69 2002 232-241
50. Kowey P.R. Yan G.X. Winkel E. Kao W. Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches Am J Cardiol 91 6A 2003 33D-38D
51. Cox J.L. Boineau J.P. Schuessler R.B. Ferguson T.B. Jr Cain M.E. Lindsay B.D. Corr P.B. Kater K.M. Lappas D.G. Successful surgical treatment of atrial fibrillation. Review and clinical update JAMA 266 1991 1976-1980
52. Cox J.L. Cardiac surgery for arrhythmias J Cardiovasc Electrophysiol 15 2004 250-262
53. Sundt T.M. III Camillo C.J. Cox J.L. The maze procedure for cure of atrial fibrillation Cardiol Clin 15 1997 739-748
54. Gillinov A.M. Blackstone E.H. McCarthy P.M. Atrial fibrillation: current surgical options and their assessment Ann Thorac Surg 74 2002 2210-2217
55. Benussi S. Nascimbene S. Agricola E. Calori G. Calvi S. Caldarola A. Oppizzi M. Casati V. Pappone C. Alfieri O. Surgical ablation of atrial fibrillation using the epicardial radiofrequency approach: mid-term results and risk analysis Ann Thorac Surg 74 2002 1050-1056 discussion 1057
56. Mohr F.W. Fabricius A.M. Falk V. Autschbach R. Doll N. Von Oppell U. Diegeler A. Kottkamp H. Hindricks G. Curative treatment of atrial fibrillation with intraoperative radiofrequency ablation: short-term and midterm results J Thorac Cardiovasc Surg 123 2002 919-927
57. Gallagher J.J. Svenson R.H. Kasell J.H. German L.D. Bardy G.H. Broughton A. Critelli G. Catheter technique for closed-chest ablation of the atrioventricular conduction system N Engl J Med 306 1982 194-200
58. Scheinman M.M. Evans-Bell T. Catheter ablation of the atrioventricular junction: a report of the percutaneous mapping and ablation registry Circulation 70 1984 1024-1029
59. Kay G.N. Ellenbogen K.A. Giudici M. Redfield M.M. Jenkins L.S. Mianulli M. Wilkoff B. and the APT Investigators The Ablate and Pace Trial (APT): a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation J Interv Card Electrophysiol 2 1998 121-135
60. Pappone C. Rosanio S. Augello G. Gallus G. Vicedomini G. Mazzone P. Gulletta S. Gugliotta F. Pappone A. Santinelli V. Tortoriello V. Sala S. Zangrillo A. Crescenzi G. Benussi S. Alfieri O. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study J Am Coll Cardiol 42 2003 185-197
61. Blommaert D. Gonzalez M. Mucumbitsi J. Gurne O. Evrard P. Buche M. Louagie Y. Eucher P. Jamart J. Installe E. De Roy L. Effective prevention of atrial fibrillation by continuous atrial overdrive pacing after coronary artery bypass surgery J Am Coll Cardiol 35 2000 1411-1415
62. Greenberg M.D. Katz N.M. Iuliano S. Tempesta B.J. Solomon A.J. A trial pacing for the prevention of atrial fibrillation after cardiovascular surgery J Am Coll Cardiol 35 2000 1416-1422
63. Israel C.W. Hohnloser S.H. Pacing to prevent atrial fibrillation J Cardiovasc Electrophysiol 14 9 Suppl 2003 S20-S26
64. Cox J.L. Ad N. Palazzo T. Fitzpatrick S. Suyderhoud J.P. DeGroot K.W. Pirovic E.A. Lou H.C. Duvall W.Z. Kim Y.D. Current status of the Maze procedure for the treatment of atrial fibrillation Semin Thorac Cardiovasc Surg 12 2000 15-19
65. Curtis A.B. Kutalek S.P. Prior M. Newhouse T.T. Ablate and Pace Trial Investigators Prevalence and characteristics of escape rhythms after radiofrequency ablation of the atrioventricular junction: results from the registry for AV junction ablation and pacing in atrial fibrillation Am Heart J 139 1 Pt 1 2000 122-125
66. Wood M.A. Brown-Mahoney C. Kay G.N. Ellenbogen K.A. Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis Circulation 101 2000 1138-1144
67. Queiroga A. Marshall H.J. Clune M. Gammage M.D. Ablate and pace revisited: long term survival and predictors of permanent atrial fibrillation Heart 89 2003 1035-1038
68. Ozcan C. Jahangir A. Friedman P.A. Patel P.J. Munger T.M. Rea R.F. Lloyd M.A. Packer D.L. Hodge D.O. Gersh B.J. Hammill S.C. Shen W.K. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation N Engl J Med 344 2001 1043-1051
69. Ozcan C. Jahangir A. Friedman P.A. Munger T.M. Packer D.L. Hodge D.O. Hayes D.L. Gersh B.J. Hammill S.C. Shen W.K. Significant effects of atrioventricular node ablation and pacemaker implantation on left ventricular function and long-term survival in patients with atrial fibrillation and left ventricular dysfunction Am J Cardiol 92 2003 33-37
70. Brignole M. Menozzi C. Gianfranchi L. Musso G. Mureddu R. Bottoni N. Lolli G. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study Circulation 98 1998 953-960
71. Weerasooriya R. Davis M. Powell A. Szili-Torok T. Shah C. Whalley D. Kanagaratnam L. Heddle W. Leitch J. Perks A. Ferguson L. Bulsara M. The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT) J Am Coll Cardiol 41 2003 1697-1702
72. Hynes B.J. Luck J.C. Wolbrette D.L. Bhatta L. Khan M. Samii S. Naccarelli G.V. Atrial fibrillation in patients with heart failure Curr Opin Cardiol 18 2003 32-38
73. Ehrlich J.R. Nattel S. Hohnloser S.H. Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets J Cardiovasc Electrophysiol 13 2002 399-405
74. Maisel W.H. Stevenson L.W. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy Am J Cardiol 91 6A 2003 2D-8D
75. McKee P.A. Castelli W.P. McNamara P.M. Kannel W.B. The natural history of congestive heart failure: the Framingham study N Engl J Med 285 1971 1441-1446
76. Kopecky S.L. Gersh B.J. McGoon M.D. Whisnant J.P. Holmes D.R. Jr Ilstrup D.M. Frye R.L. The natural history of lone atrial fibrillation. A population-based study over three decades N Engl J Med 317 1987 669-674
77. Doval H.C. Nul D.R. Grancelli H.O. Perrone S.V. Bortman G.R. Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) Lancet 344 1994 493-498
78. Pozzoli M. Cioffi G. Traversi E. Pinna G.D. Cobelli F. Tavazzi L. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm J Am Coll Cardiol 32 1998 197-204
79. Braunwald E. Shattuck lecture - cardiovasciolar medicime at the turn of the millennium: triumphs, concerns, and oppurtunities N Engl J Med 337 1997 1360-1369
80. Wattigney W.A. Mensah G.A. Croft J.B. Increased atrial fibrillation mortality: United States, 1980-1998 Am J Epidemiol 155 2002 819-826
81. Stewart S. MacIntyre K. Chalmers J.W. Boyd J. Finlayson A. Redpath A. Pell J.P. Capewell S. McMurray J.J. Trends in case-fatality in 22968 patients admitted for the first time with atrial fibrillation in Scotland, 1986-1995 Int J Cardiol 82 2002 229-236
82. Wang T.J. Larson M.G. Levy D. Vasan R.S. Leip E.P. Wolf P.A. D'Agostino R.B. Murabito J.M. Kannel W.B. Benjamin E.J. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study Circulation 107 2003 2920-2925
83. Aronow W.S. Ahn C. Kronzon I. Prognosis of congestive heart failure after prior myocardial infarction in older persons with atrial fibrillation versus sinus rhythm Am J Cardiol 87 2001 224-225 A8-A9
84. Pedersen O.D. Bagger H. Keller N. Marchant B. Kober L. Torp-Pedersen C. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (DIAMOND) substudy Circulation 104 2001 292-296
85. Mathew J. Hunsberger S. Fleg J. Mc Sherry F. Williford W. Yusuf S. Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure Chest 118 2000 914-922
86. Crijns H.J. Tjeerdsma G. de Kam P.J. Boomsma F. van Gelder I.C. van den Berg M.P. van Veldhuisen D.J. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure Eur Heart J 21 2000 1238-1245
87. Dries D.L. Exner D.V. Gersh B.J. Domanski M.J. Waclawiw M.A. Stevenson L.W. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction J Am Coll Cardiol 32 1998 695-703
88. Maggioni A.P. Gregorio L. Gorini M. Predictors of 1 year mortality in 2086 outpatients with congestive heart failure: data from Italian network of congestive heart failure J Am Coll Cardiol 31 A Suppl 1998 218A (abstr)
89. Stevenson W.G. Stevenson L.W. Middlekauff H.R. Fonarow G.C. Hamilton M.A. Woo M.A. Saxon L.A. Natterson P.D. Steimle A. Walden J.A. Tillisch J.H. Improving survival for patients with atrial fibrillation and advanced heart failure J Am Coll Cardiol 28 1996 1458-1463
90. Carson P.E. Johnson G.R. Dunkman W.B. Fletcher R.D. Farrell L. Cohn J.N. The V-HeFT VA Cooperative Studies Group The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies Circulation 87 6 Suppl 1993 VI102-VI110
91. Bourassa M.G. Gurne O. Bangdiwala S.I .Ghali J.K. Young J.B. Rousseau M. Johnstone D.E. Yusuf S. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators Natural history and patterns of current practice in heart failure J Am Coll Cardiol 22 4 Suppl A 1993 14A-19A
92. Middlekauff H.R. Stevenson W.G. Stevenson L.W. A study of 390 patients Prognostic significance of atrial fibrillation in advanced heart failure Circulation 84 1991 40-48
93. Mahoney P. Kimmel S. DeNofrio D. Wahl P. Loh E. Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure Am J Cardiol 83 1999 1544-1547
94. Wong C.K. White H.D. Wilcox R.G. Criger D.A. Califf R.M. Topol E.J. Ohman E.M. during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries Heart 88 2002 357-362
95. Deedwania P.C. Singh B.N. Ellenbogen K. Fisher S. Fletcher R. Singh S.N. The Department of Veterans Affairs CHF-STAT Investigators Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT) Circulation 98 1998 2574-2579
96. Hylek E.M. Go A.S. Chang Y. Jensvold N.G. Henault L.E. Selby J.V. Singer D.E. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation N Engl J Med 349 2003 1019-1026
97. Grigioni F. Avierinos J.F. Ling L.H. Scott C.G. Bailey K.R. Tajik A.J. Frye R.L. Enriquez-Sarano M. Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome J Am Coll Cardiol 40 2002 84-92
98. Wong C.K. White H.D. Wilcox R.G. Criger D.A. Califf R.M. Topol E.J. Ohman E.M. New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience Am Heart J 140 2000 878-885
99. Kinjo K. Sato H. Sato H. Ohnishi Y. Hishida E. Nakatani D. Mizuno H. Fukunami M. Koretsune Y. Takeda H. Hori M. Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention Am J Cardiol 92 2003 1150-1154